BlackRock, through partners Securitize and Ethena Labs, has launched a $100 million liquidity facility enabling eligible investors to swap shares of its tokenized money market fund BUIDL for stablecoins such as USDC at any time, including outside traditional market hours. This facility starts with $50 million in liquidity split evenly between BUIDL and USDC, with an additional $50 million reserve that activates as needed. The move enhances liquidity for institutional holders, allowing them to access stablecoins around the clock, reducing risks associated with market closures. This development also strengthens the integration between BlackRock's fund, Securitize's transfer agent role, and Ethena's stablecoin, potentially impacting all linked products during market stress. The facility is limited to eligible investors and is designed to support smoother transactions between BUIDL and stablecoins.
The $100 million liquidity facility launched by Securitize and Ethena for BlackRock's BUIDL is presented here with Pluang market data for context. For readers following major cryptocurrencies, 6 out of 50 priced assets rose while 43 fell as of Nov 12, 2026 20:32 WIB. Notable moves include BAL (Balancer) up 11.14% at Rp16.297, AAVE (Aave) down 9.54% at Rp2.024.701 with a 36% sell order activity, and SXP (Solar) down 46.27% at Rp37, with a typical hold time of 94 days on Pluang.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
